Clinical impact of an accurate genetic characterisation of older AML patients

Circulating tumour-cell count used to decide between treatments for breast cancer patients

Accelerated partial breast irradiation not equivalent to whole breast irradiation

Axillary radiotherapy and surgery show comparable long term outcomes for patients with breast cancer

Low-dose tamoxifen reduces recurrence and new breast disease

Adjuvant capecitabine did not significantly improve outcomes for breast cancer patients

Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer patients

Two clinical trials using combination therapy in adult patients with multiple myeloma

Scalp cooling to prevent chemotherapy induced alopecia in breast cancer patients

Role of chemotherapy in the treatment of metastatic breast cancer patients

Recent data on eribulin in metastatic breast cancer patients from SABCS 2018

The combined analysis of carfilzomib trials for multiple myeloma